FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Flum Joshua Matthew
2. Issuer Name and Ticker or Trading Symbol

CVS HEALTH Corp [ CVS ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
EVP, ENT STRATEGY & DIGITAL
(Last)          (First)          (Middle)

ONE CVS DRIVE
3. Date of Earliest Transaction (MM/DD/YYYY)

4/1/2020
(Street)

WOONSOCKET, RI 02895
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 4/1/2020  F  973 (1)D$58.34 25000.958 D  
Common Stock (restricted)         11545 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option $58.61 (2)4/1/2020  A   63358    4/1/2021 (3)4/1/2030 Common Stock 63358 $58.61 63358 D  
Stock Option $34.96           4/1/2014 (4)4/1/2021 Common Stock 21460  21460 D  
Stock Option $74.29           4/1/2015 (5)4/1/2021 Common Stock 25177  25177 D  
Stock Option $102.26           4/1/2016 (6)4/1/2022 Common Stock 17822  17822 D  
Stock Option $104.82           4/1/2017 (7)4/1/2023 Common Stock 17611  17611 D  
Stock Option $103.87           2/27/2018 (8)2/27/2025 Common Stock 24060  24060 D  
Stock Option $78.05           4/3/2018 (9)4/3/2024 Common Stock 30169  30169 D  
Stock Option $62.21           4/1/2019 (10)4/1/2025 Common Stock 22541  22541 D  
Stock Option $54.19           4/1/2020 (11)4/1/2029 Common Stock 60602  60602 D  

Explanation of Responses:
(1) Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.
(2) The number of shares subject to the option were calculated using a 30-day average price.
(3) Option becomes exercisable in four equal annual installments, commencing 4/1/2021.
(4) Options became exercisable in three equal annual installments beginning on 4/1/2014.
(5) Options became exercisable in four equal annual installments beginning on 4/1/2015.
(6) Options became exercisable in four equal annual installments beginning on 4/1/2016.
(7) Options became exercisable in four equal annual installments beginning on 4/1/2017.
(8) Options became exercisable in three equal annual installments beginning on 2/27/2018.
(9) Options became exercisable in four equal annual installments beginning on 4/3/2018.
(10) Option became exercisable in four equal annual installments, commencing 4/1/2019.
(11) Option became exercisable in four equal annual installments, commencing 4/1/2020.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Flum Joshua Matthew
ONE CVS DRIVE
WOONSOCKET, RI 02895


EVP, ENT STRATEGY & DIGITAL

Signatures
/s/ Joshua M. Flum4/3/2020
**Signature of Reporting PersonDate

CVS Health (NYSE:CVS)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more CVS Health Charts.
CVS Health (NYSE:CVS)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more CVS Health Charts.